Growth Metrics

Capricor Therapeutics (CAPR) Debt Ratio (2016 - 2024)

Historic Debt Ratio for Capricor Therapeutics (CAPR) over the last 16 years, with Q3 2024 value amounting to 0.04.

  • Capricor Therapeutics' Debt Ratio fell 6003.05% to 0.04 in Q3 2024 from the same period last year, while for Sep 2024 it was 0.04, marking a year-over-year decrease of 6003.05%. This contributed to the annual value of 0.06 for FY2023, which is 1690.55% down from last year.
  • Capricor Therapeutics' Debt Ratio amounted to 0.04 in Q3 2024, which was down 6003.05% from 0.09 recorded in Q2 2024.
  • Capricor Therapeutics' Debt Ratio's 5-year high stood at 0.24 during Q1 2020, with a 5-year trough of 0.04 in Q3 2024.
  • Its 5-year average for Debt Ratio is 0.08, with a median of 0.08 in 2021.
  • As far as peak fluctuations go, Capricor Therapeutics' Debt Ratio plummeted by 8031.88% in 2020, and later skyrocketed by 4162.39% in 2023.
  • Over the past 5 years, Capricor Therapeutics' Debt Ratio (Quarter) stood at 0.1 in 2020, then decreased by 1.37% to 0.1 in 2021, then decreased by 28.08% to 0.07 in 2022, then dropped by 16.91% to 0.06 in 2023, then crashed by 36.81% to 0.04 in 2024.
  • Its last three reported values are 0.04 in Q3 2024, 0.09 for Q2 2024, and 0.07 during Q1 2024.